PATENT CLAIM ANALYSIS

Application Number: 15868567
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["424", "133100"]

Abstract:
Antibody formulations and methods useful for prophylaxis or treatment of amyloidosis, including AA amyloidosis and AL amyloidosis.

Claim (Index 58):
A method of therapeutically or prophylactically treating a human patient having or at risk for having amyloidosis characterized by the presence of amyloid protein fibrils, the method comprising administering to the patient an effective dosage of the formulation of any one of  claims 1 - 33 .

Metadata:
- Claim Count in Document: 14.0
- Percentile: 86.0
- Lexical Diversity: 1.1875
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13660957', '13187093', '12345650', '13314160', '12811049']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7814700256320039
- 35 USC 102 Novelty (BERT): 0.5848477188966071
- Combined Prediction Score: 0.7618077949584642
- Mean Citation Score: 433.22061
- Max Citation Score: 545.3246
- Similarity Product: 411.2637159375429

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test